Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Detection of Gross Error: The Q Test01:00

Detection of Gross Error: The Q Test

5.0K
When one or more data points appear far from the rest of the data, there is a need to determine whether they are outliers and whether they should be eliminated from the data set to ensure an accurate representation of the measured value. In many cases, outliers arise from gross errors (or human errors) and do not accurately reflect the underlying phenomenon. In some cases, however, these apparent outliers reflect true phenomenological differences. In these cases, we can use statistical methods...
5.0K
Quantifying and Rejecting Outliers: The Grubbs Test01:02

Quantifying and Rejecting Outliers: The Grubbs Test

1.4K
Sometimes, a data set can have a recorded numerical observation that greatly  deviates from the rest of the data. Assuming that the data is normally distributed, a statistical method called the Grubbs test can be used to determine whether the observation is truly an outlier.  To perform a two-tailed Grubbs test, first, calculate the absolute difference between the outlier and the mean. Then, calculate the ratio between this difference and the standard deviation of the sample. This...
1.4K
Censoring Survival Data01:09

Censoring Survival Data

54
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
54
Data Validation01:15

Data Validation

129
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
129
Decision Making: Traditional Method01:14

Decision Making: Traditional Method

3.9K
The process of hypothesis testing based on the traditional method includes calculating the critical value, testing the value of the test statistic using the sample data, and interpreting these values.
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
3.9K
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

165
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
165

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

African American Dementia Caregiver Strategies Inventory: Initial descriptive and psychometric evaluation.

Rehabilitation psychology·2026
Same author

Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin Structure Infections.

Open forum infectious diseases·2026
Same author

Adjusting for covariates in randomized clinical trials for drugs and biological products.

Clinical trials (London, England)·2025
Same author

AI-Enabled Personalized Smoking Cessation Intervention With the Aipaca Chatbot: Mixed Methods Feasibility Study.

JMIR formative research·2025
Same author

Evaluating Viral Load Sampling Schemes and Swabbing Methods for Optimal Surrogacy.

The Journal of infectious diseases·2025
Same author

Interagency Collaboration for Patient-Centered Antibacterial Drug Development.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: May 20, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

A Tipping Point Method to Evaluate Sensitivity to Potential Violations in Missing Data Assumptions.

Cesar Torres1, Gregory Levin1, Daniel Rubin1

  • 1Food and Drug Administration, Silver Spring, Maryland, USA.

Pharmaceutical Statistics
|March 27, 2025
PubMed
Summary
This summary is machine-generated.

Evaluating clinical trial conclusions requires robust sensitivity analyses for missing data. A novel tipping point analysis systematically explores assumption violations, ensuring reliable treatment effect findings under all plausible scenarios.

Keywords:
clinical trialsmissing datasensitivity analysistipping point

More Related Videos

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.2K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

13.6K

Related Experiment Videos

Last Updated: May 20, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K
Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects
08:13

Using the Race Model Inequality to Quantify Behavioral Multisensory Integration Effects

Published on: May 10, 2019

6.2K
A Tactile Automated Passive-Finger Stimulator TAPS
19:44

A Tactile Automated Passive-Finger Stimulator TAPS

Published on: June 3, 2009

13.6K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Regulatory Science

Background:

  • Clinical trial conclusions are sensitive to missing data assumptions.
  • Existing sensitivity analyses may not comprehensively explore all plausible scenarios.

Purpose of the Study:

  • To introduce a novel tipping point analysis for systematically evaluating sensitivity to missing data assumptions in clinical trials.
  • To ensure key conclusions remain robust under all plausible missing data scenarios.

Main Methods:

  • Developed a tipping point analysis approach for quantitative or quasi-quantitative outcomes.
  • Inference is based on observed data and two sensitivity parameters (mean differences in outcomes between dropouts and completers).
  • Derived asymptotic properties of the proposed statistic, avoiding imputation.

Main Results:

  • The tipping point analysis systematically explores the space of possible assumptions.
  • Identified scenarios where treatment effect evidence diminishes or disappears.
  • Demonstrated utility in two drug review examples informing regulatory decisions.

Conclusions:

  • The proposed tipping point analysis provides a comprehensive method for sensitivity analysis in clinical trials.
  • This approach enhances the reliability of treatment effect conclusions by assessing robustness to missing data.
  • The methodology aids regulatory decision-making by evaluating findings under various missing data assumptions.